Table 1 Clinical-pathological data of 44 breast cancer patients.
Clinical Parameter | Median (Range) | n | (%) |
|---|---|---|---|
Age (years) | 52 (27–77) | ||
Menopausal status | |||
Premenopausal | 21 | (47.7) | |
Postmenopausal | 23 | (52.3) | |
Clinical Stage | |||
II | 14 | (31.8) | |
III/IV | 30 | (68.2) | |
Histologic Grade | |||
Low | 12 | (27.3) | |
Intermediate and High | 32 | (72.7) | |
Tumoral Size | |||
< 5 cm | 21 | (47.7) | |
> 5 cm | 23 | (52.3) | |
Axillary node status | |||
Positive | 25 | (56.8) | |
Negative | 15 | (34.1) | |
Treatment Response | |||
Complete Response (CR) | 29 | (65.9) | |
Partial Response (PR) or No Response (NR) | 15 | (34.1) | |
Telomerase activity | |||
Positive | 26 | (59) | |
Negative | 18 | (41) | |
Estrogen Receptor α | |||
Positive | 39 | (88) | |
Negative | 5 | (12) | |
Estrogen Receptor β | |||
Positive | 16 | (36) | |
Negative | 28 | (64) | |
Bcl-2 | |||
Positive | 35 | (79.5) | |
Negative | 9 | (20.4) |